Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo Candida albicans vascular catheter infection and ex vivo Candida auris skin colonization

New antifungal therapies are needed for both systemic, invasive infections as well as superficial infections of mucosal and skin surfaces as well as biofilms associated with medical devices. The resistance of biofilm and biofilm-like growth phases of fungi contributes to the poor efficacy of systemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beattie, Sarah R., Esan, Taiwo, Zarnowski, Robert, Eix, Emily, Nett, Jeniel E., Andes, David R., Hagen, Timothy, Krysan, Damian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882332/
https://www.ncbi.nlm.nih.gov/pubmed/36711909
http://dx.doi.org/10.1101/2023.01.19.524835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882332/
https://www.ncbi.nlm.nih.gov/pubmed/36711909
http://dx.doi.org/10.1101/2023.01.19.524835

Ejemplares similares